NeilMBresslerMD
Ophthalmology • Baltimore, MDRetinal Disease
Professor of Ophthalmology, Johns Hopkins University School of Medicine; Chief - Retina Division
Are you Dr. Bressler?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 112 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1800 Orleans Street
Maumenee Lobby
Baltimore, MD 21287
Summary
- Dr. Neil Bressler, MD is a board certified ophthalmologist in Baltimore, Maryland. He is currently licensed to practice medicine in Maryland and Pennsylvania. He is affiliated with Johns Hopkins Hospital and Johns Hopkins Bayview Medical Center.
Education & Training
Johns Hopkins UniversityResidency, Ophthalmology, 1986 - 1988
Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolResidency, Ophthalmology, 1983 - 1986- Johns Hopkins University School of MedicineInternship, Transitional Year, 1982 - 1983
- Johns Hopkins University School of MedicineClass of 1982
Certifications & Licensure
MD State Medical License 1982 - 2026
PA State Medical License 2020 - 2022- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2004-2014
- Top Doctors:Baltimore Area Castle Connolly, 2012
- Top Doctors:Washington-Baltimore Castle Connolly, 2012
- Join now to see all
Clinical Trials
- Neovascular Age Related Macular Degeneration (AMD), Periocular Corticosteroids, and Photodynamic Therapy (PDT) Start of enrollment: 2002 Jul 01
- Ranibizumab in Hemorrhagic Choroidal Neovascularization Trial Start of enrollment: 2006 Aug 01
- Ranibizumab in Idiopathic Parafoveal Telangiectasia (RIPT) Trial Start of enrollment: 2006 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- Clinically Meaningful Change Estimates for the National Eye Institute Visual Function Questionnaire-25 in Patients With Diabetic Macular Edema.Neil Bressler, Zdenka Haskova, Audrey Kapre, Brittany Gentile
Translational Vision Science & Technology. 2024-12-02 - Intraocular Pressure Outcomes After Lampalizumab Injections in Patients With Geographic Atrophy.Neil M Bressler, K Bailey Freund, Sophie J Bakri, Judy E Kim, Daniela Ferrara
JAMA Ophthalmology. 2024-08-01 - Association of baseline factors with 1-year outcomes in the SB11-ranibizumab equivalence trial: A post hoc analysis.Se Joon Woo, Jin Ah Jung, Taehyung Kim, Inkyung Oh, Mercy Yeeun Kim
Asia-Pacific Journal of Ophthalmology. 2024-05-15
Authored Content
- Ophthalmology and COVID-19September 2020
Press Mentions
James and Heather Gills Donate $10 Million to Wilmer Eye Institute, Johns Hopkins MedicineOctober 3rd, 2024- Detection and Referral of Depression in Patients with Visual ImpairmentSeptember 19th, 2024
- Biomarker Detection and Validation for Corneal Involvement in Patients with Acute Infectious ConjunctivitisAugust 15th, 2024
- Join now to see all
Grant Support
- Diabetic Retinopathy Clinical Research Network Operations CenterNational Eye Institute2009–2012
- Submacular Surgery Trials--Study Chairman'S Office GrantNational Eye Institute1996–2005
- Submacular Surgery Trials--Study Chairmans Office GrantNational Eye Institute1997–1999
- Submacular Surgery TrialsNational Eye Institute1995
- Macular Photocoagulation Study Reading CenterNational Eye Institute1991–1995
- Macular Photocoagulation StudyNational Eye Institute1992–1993
Professional Memberships
- Fellow
